Commission Implementing Regulation (EU) No. 1197/2012 amending Implementing Regulation (EU) No. 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, alpha-cypermethrin, Ampelomyces quisqualis Strain: AQ 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum Strain: J1446, imazosulfuron, laminarin, mepanipyrim.
Country
Type of law
Legislation
Abstract
This Regulation lays down some amendments to Part A of the Annex to Regulation (EU) No. 540/2011 as regards the extension of the approval periods of the active substances acetamiprid, alpha-cypermethrin, Ampelomyces quisqualis Strain: AQ 10, benalaxyl, bifenazate, bromoxynil, chlorpropham, desmedipham, etoxazole, Gliocladium catenulatum Strain: J1446, imazosulfuron, laminarin, mepanipyrim, methoxyfenozide, milbemectin, phenmedipham, Pseudomonas chlororaphis Strain: MA 342, quinoxyfen, S-metolachlor, tepraloxydim, thiacloprid, thiram and ziram.
Attached files
Web site
Date of text
Repealed
No
Serial Imprint
Official Journal of the European Union L 342, 14 December 2012, pp. 27-30.
Source language
English
Legislation Amendment
No